US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 12.660
  • +0.180+1.44%
Close Nov 27 16:00 ET
  • 12.780
  • +0.120+0.95%
Post 20:01 ET
534.24MMarket Cap-4192P/E (TTM)

About UroGen Pharma Ltd Company

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

Company Profile

SymbolURGN
Company NameUroGen Pharma Ltd
Listing DateMay 4, 2017
Issue Price13.00
Founded2004
CEOMs. Elizabeth Barrett
MarketNASDAQ
Employees201
Fiscal Year Ends12-31
Address400 Alexander Park Drive,4th floor
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-646-768-9780
Websitehttp://www.urogen.com

Company Executives

  • Name
  • Position
  • Salary
  • Elizabeth Barrett
  • Director, President and Chief Executive Officer
  • 4.64M
  • Dr. Mark P. Schoenberg, M.D.
  • Chief Medical Officer
  • 1.36M
  • Jason Drew Smith
  • General Counsel, Chief Compliance Officer and Corporate Secretary
  • 1.51M
  • Christopher Degnan
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Arie S. Belldegrun, F.A.C.S.,M.D.
  • Chairman of the Board
  • 342.18K
  • James A. Robinson, Jr
  • Independent Director
  • 313.29K
  • Cynthia M. Butitta
  • Independent Director
  • 204.06K
  • Daniel George Wildman
  • Independent Director
  • 192.72K
  • Dr. Stuart Holden, M.D.
  • Independent Director
  • 201.53K
  • Dr. Leana S. Wen, M. Sc.,M.D.
  • Independent Director
  • 194.41K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data